1 - 25 of 93 results for author:"Vestweber D." in Literature citations
Results Customize
› Repeat search in UniProtKB (33)
| The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Gaengel K., Niaudet C., Hagikura K., Lavina B., Siemsen B.L., Muhl L., Hofmann J.J., Ebarasi L., Nystrom S., Rymo S. et al. Dev. Cell 23:587-599(2012) · Mapped (52) |
| Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. Broermann A., Winderlich M., Block H., Frye M., Rossaint J., Zarbock A., Cagna G., Linnepe R., Schulte D., Nottebaum A.F. et al. J. Exp. Med. 208:2393-2401(2011) · Mapped (2) |
| Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. Schulte D., Kuppers V., Dartsch N., Broermann A., Li H., Zarbock A., Kamenyeva O., Kiefer F., Khandoga A., Massberg S. et al. EMBO J. 30:4157-4170(2011) · Mapped (2) |
| Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo. Schnoor M., Lai F.P., Zarbock A., Klaver R., Polaschegg C., Schulte D., Weich H.A., Oelkers J.M., Rottner K., Vestweber D. J. Exp. Med. 208:1721-1735(2011) · Mapped (3) |
| GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Kempf T., Zarbock A., Widera C., Butz S., Stadtmann A., Rossaint J., Bolomini-Vittori M., Korf-Klingebiel M., Napp L.C., Hansen B. et al. Nat. Med. 17:581-588(2011) · Mapped (7) |
| Endothelial LSP1 is involved in endothelial dome formation, minimizing vascular permeability changes during neutrophil transmigration in vivo. Petri B., Kaur J., Long E.M., Li H., Parsons S.A., Butz S., Phillipson M., Vestweber D., Patel K.D., Robbins S.M. et al. Blood 117:942-952(2011) · Mapped (4) |
| von Willebrand factor promotes leukocyte extravasation. Petri B., Broermann A., Li H., Khandoga A.G., Zarbock A., Krombach F., Goerge T., Schneider S.W., Jones C., Nieswandt B. et al. Blood 116:4712-4719(2010) · Mapped (11) |
| CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Bixel M.G., Li H., Petri B., Khandoga A.G., Khandoga A., Zarbock A., Wolburg-Buchholz K., Wolburg H., Sorokin L., Zeuschner D. et al. |
| Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Jurisic G., Sundberg J.P., Bleich A., Leiter E.H., Broman K.W., Buechler G., Alley L., Vestweber D., Detmar M. Genes Immun. 11:219-231(2010) · Mapped (8) |
| A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis. Tanne A., Ma B., Boudou F., Tailleux L., Botella H., Badell E., Levillain F., Taylor M.E., Drickamer K., Nigou J. et al. J. Exp. Med. 206:2205-2220(2009) · Mapped (16) |
| VE-PTP controls blood vessel development by balancing Tie-2 activity. Winderlich M., Keller L., Cagna G., Broermann A., Kamenyeva O., Kiefer F., Deutsch U., Nottebaum A.F., Vestweber D. J. Cell Biol. 185:657-671(2009) · UniProtKB (4) · Mapped (9) |
| Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Wu C., Ivars F., Anderson P., Hallmann R., Vestweber D., Nilsson P., Robenek H., Tryggvason K., Song J., Korpos E. et al. Nat. Med. 15:519-527(2009) · Mapped (12) |
| EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Seizer P., Borst O., Langer H.F., Bultmann A., Munch G., Herouy Y., Stellos K., Kramer B., Bigalke B., Buchele B. et al. Thromb. Haemost. 101:682-686(2009) · Mapped (24) |
| Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. Kharabi Masouleh B., Ten Dam G.B., Wild M.K., Seelige R., van der Vlag J., Rops A.L., Echtermeyer F.G., Vestweber D., van Kuppevelt T.H., Kiesel L. et al. J. Immunol. 182:4985-4993(2009) · Mapped (4) |
| The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice. Yokota T., Oritani K., Butz S., Kokame K., Kincade P.W., Miyata T., Vestweber D., Kanakura Y. Blood 113:2914-2923(2009) · Mapped (6) |
| The adhesion molecule esam1 is a novel hematopoietic stem cell marker. Ooi A.G., Karsunky H., Majeti R., Butz S., Vestweber D., Ishida T., Quertermous T., Weissman I.L., Forsberg E.C. Stem Cells 27:653-661(2009) · Mapped (6) |
| VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Nottebaum A.F., Cagna G., Winderlich M., Gamp A.C., Linnepe R., Polaschegg C., Filippova K., Lyck R., Engelhardt B., Kamenyeva O. et al. J. Exp. Med. 205:2929-2945(2008) · UniProtKB (2) · Mapped (7) |
| Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Pfeiffer F., Kumar V., Butz S., Vestweber D., Imhof B.A., Stein J.V., Engelhardt B. Eur. J. Immunol. 38:2142-2155(2008) · Mapped (7) |
| Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. Frommhold D., Ludwig A., Bixel M.G., Zarbock A., Babushkina I., Weissinger M., Cauwenberghs S., Ellies L.G., Marth J.D., Beck-Sickinger A.G. et al. J. Exp. Med. 205:1435-1446(2008) · Mapped (6) |
| Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Saharinen P., Eklund L., Miettinen J., Wirkkala R., Anisimov A., Winderlich M., Nottebaum A., Vestweber D., Deutsch U., Koh G.Y. et al. Nat. Cell Biol. 10:527-537(2008) · UniProtKB (2) · Mapped (4) |
| A single Caenorhabditis elegans Golgi apparatus-type transporter of UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, and UDP-N-acetylgalactosamine. Caffaro C.E., Luhn K., Bakker H., Vestweber D., Samuelson J., Berninsone P., Hirschberg C.B. Biochemistry 47:4337-4344(2008) · Mapped (2) |
| Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Labelle M., Schnittler H.J., Aust D.E., Friedrich K., Baretton G., Vestweber D., Breier G. Cancer Res. 68:1388-1397(2008) · Mapped (11) |
| Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice. van Wanrooij E.J., de Vos P., Bixel M.G., Vestweber D., van Berkel T.J., Kuiper J. Cardiovasc. Res. 78:590-596(2008) · Mapped (7) |
| Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. Turowski P., Martinelli R., Crawford R., Wateridge D., Papageorgiou A.P., Lampugnani M.G., Gamp A.C., Vestweber D., Adamson P., Dejana E. et al. J. Cell. Sci. 121:29-37(2008) · Mapped (16) |
| E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. Doring A., Wild M., Vestweber D., Deutsch U., Engelhardt B. J. Immunol. 179:8470-8479(2007) · Mapped (5) |